FGC
IART icon

Financial Gravity Companies’s Integra LifeSciences IART Stock Holding History

Financial Gravity Companies’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$11K Buy
175
+157
+872% +$8.23K 0.01% 576
2017
Q4 		$1K Buy
+18
New +$881 ﹤0.01% 1127

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Financial Gravity Companies's IART Position: Q1 2018 in Review

Financial Gravity Companies increased its Integra LifeSciences (IART) stake by 872% in Q1 2018, buying an estimated $8.23K and bringing the position to 175 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #576.

Financial Gravity Companies first reported a position in IART in Q4 2017 and has held it in 2 quarters since. 235 funds tracked by Wall St. Rank hold IART as of Q1 2018.

  • Financial Gravity Companies held 175 shares of Integra LifeSciences worth $11K as of Q1 2018.
  • Financial Gravity Companies bought 157 Integra LifeSciences shares in Q1 2018, an estimated $8.23K.
  • Integra LifeSciences made up 0.01% of Financial Gravity Companies's portfolio in Q1 2018, its #576 holding.
  • Financial Gravity Companies first reported a position in Integra LifeSciences in Q4 2017 and has held it in 2 quarters since.
  • 235 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2018.

Based on Financial Gravity Companies's 13F filing for Q1 2018, filed 4 May 2018.